Team:Exeter/Concept

From 2012.igem.org

(Difference between revisions)
m (put breaks in)
Line 42: Line 42:
<p><b><u><a href="https://2012.igem.org/Team:Exeter/lab_book/1gp/wk1"; style="color:#57b947">Showcasing Polysaccharides</a></u></b></p><br>
<p><b><u><a href="https://2012.igem.org/Team:Exeter/lab_book/1gp/wk1"; style="color:#57b947">Showcasing Polysaccharides</a></u></b></p><br>
       </font>
       </font>
-
<p>Before considering GTase combinations however, we asked whether we could synthesise useful polysaccharides in <i>Escherichia coli</i> with single genes. Evolution has provided us with a remarkable variety of polysaccharides that have unique properties and countless uses. Their applications in medicine, industry, food, cosmetics, engineering etc. have been recognised and the biological synthesis of some of these polysaccharides, to avoid issues with limited bioavailability, is a recent development.</p><br>
+
<p>Before considering GTase combinations however, we asked whether we could synthesise useful polysaccharides in <i>Escherichia coli</i> with single genes. Evolution has provided us with a remarkable variety of polysaccharides that have unique properties and countless uses. Their applications in medicine, industry, food, cosmetics, engineering etc. have been recognised and the biological synthesis of some of these polysaccharides, to avoid issues with limited bioavailability and the tedious chemical syntesis methods, is a recent development.</p><br>
<p>The three polysaccharides:</p><br>
<p>The three polysaccharides:</p><br>
-
<p>Hyaluronan is a powerful lubricant found in human joints and skin which has medical applications from surgical glues to skin moisturisers.</p><br>
+
<p>Hyaluronan is a powerful lubricant found in human joints and skin which has vast medical applications from joint lubricators and surgical glues, as well as cosmetic applications in skin moisturisers.</p><br>
-
<p> Levansucrose is a potential glue recognised by Newcastle iGEM 2010 (BacillaFilla) that could repair cracks in concrete. The addition of a signal peptide, <i>ompA</i>, was planned to ensure expression of Levansucrase outside the cell.  Within the cell, levansucrose has toxic properties which prevent it being made without cell death and give it use as a selection marker. We hoped export from the cell would give it dual use.</p><br>
+
<p> Levansucrose is a potential glue recognised by Newcastle iGEM 2010 (BacillaFilla) that could repair cracks in concrete. The addition of a signal peptide, <i>ompA</i>, was planned to ensure expression of Levansucrase outside the cell.  Within the cell, levansucrose has toxic properties which prevent it being made without cell death and give it use as a selection marker. We hoped export from the cell would give it dual use and enable the levansucrose to accumulate to explore it's sticky properties.</p><br>
-
<p> The third polysaccharide we are producing is a cyclic oligosaccharide made from starch rather than a linear polysaccharide - cyclodextrin. Cyclodextrin has important medical applications as a drug delivery system, and food applications through the removal of cholesterol. We also wanted to add the cyclodextrin gene (<i>amyA</i>) to the <i>ompA</i> signal peptide to prevent cell death through toxicity.</p><br>
+
<p> The third polysaccharide we are producing is a cyclic oligosaccharide made from starch rather than a linear polysaccharide - cyclodextrin. Cyclodextrin has important medical applications as a drug delivery system, and food applications through the removal of cholesterol.</p><br>
<p>We have built biobricks coding for HA synthase (hyaluronan production), cyclodextrin glycosyltransferase (GTase; cyclodextrin production) and have modified the existing <i>sacB</i> biobrick to attempt extracellular levansucrose biosynthesis in <i>E. coli</i>. In so doing we have introduced an <i>ompA</i> export signal peptide coding sequence to the registry.</p><br>
<p>We have built biobricks coding for HA synthase (hyaluronan production), cyclodextrin glycosyltransferase (GTase; cyclodextrin production) and have modified the existing <i>sacB</i> biobrick to attempt extracellular levansucrose biosynthesis in <i>E. coli</i>. In so doing we have introduced an <i>ompA</i> export signal peptide coding sequence to the registry.</p><br>

Revision as of 15:13, 26 September 2012

Concept

The Concept of Our Miniprojects

Polysaccharides - polymers of sugar molecules - have a spectacular range of properties and uses, from the structural (cellulose) and medicinal (bacterial vaccines, cyclodextrin) to foods (starch), glues (levan) and lubricants (hyaluronan (HA)). This range of properties stem from both the chemical nature of the sugars, their physical arrangement within the polymer and the macro-scale arrangement of the polymer itself.


Currently, scientific research relies on the study of polysaccharides isolated from their native source and subsequent modification, or on expensive, time-consuming and potentially environmentally-polluting production via synthetic chemistry.


This project, e-candi, aims to investigate whether synthetic biology could provide a platform to revolutionise polysaccharide research by allowing rapid biosynthesis of designer polysaccharides. We posed a range of questions to test whether this might be possible.



GlycoBase/GlycoWeb


So why do we need a database and what should it be capable of?


We identified the endogenous Wzy-dependent polysaccharide biosynthesis machinery as a suitable target for manipulation by heterologous expression of E. coli Glycosyltransferases (GTases). GTases are specific to different donor and acceptor monosaccharides. The database makes it possible to find an enzyme combination which will correctly connect monosaccharides to create the polysaccharide of design. This will improve the efficiency of the polysaccharide lab work and speed up the process of polysaccharide production.


It is not unforeseeable that there may be more than one enzymatic approach to producing a particular polysaccharide; as a long term aim of the database project, it may be possible that our database could return some of the advantages/disadvantages of certain construction pathways. Indeed if some repeating units are not possible, the database could suggest similar or alternative products with ‘nearly’ identical properties.



Showcasing Polysaccharides


Before considering GTase combinations however, we asked whether we could synthesise useful polysaccharides in Escherichia coli with single genes. Evolution has provided us with a remarkable variety of polysaccharides that have unique properties and countless uses. Their applications in medicine, industry, food, cosmetics, engineering etc. have been recognised and the biological synthesis of some of these polysaccharides, to avoid issues with limited bioavailability and the tedious chemical syntesis methods, is a recent development.


The three polysaccharides:


Hyaluronan is a powerful lubricant found in human joints and skin which has vast medical applications from joint lubricators and surgical glues, as well as cosmetic applications in skin moisturisers.


Levansucrose is a potential glue recognised by Newcastle iGEM 2010 (BacillaFilla) that could repair cracks in concrete. The addition of a signal peptide, ompA, was planned to ensure expression of Levansucrase outside the cell. Within the cell, levansucrose has toxic properties which prevent it being made without cell death and give it use as a selection marker. We hoped export from the cell would give it dual use and enable the levansucrose to accumulate to explore it's sticky properties.


The third polysaccharide we are producing is a cyclic oligosaccharide made from starch rather than a linear polysaccharide - cyclodextrin. Cyclodextrin has important medical applications as a drug delivery system, and food applications through the removal of cholesterol.


We have built biobricks coding for HA synthase (hyaluronan production), cyclodextrin glycosyltransferase (GTase; cyclodextrin production) and have modified the existing sacB biobrick to attempt extracellular levansucrose biosynthesis in E. coli. In so doing we have introduced an ompA export signal peptide coding sequence to the registry.



Operon Construction


Secondly, we asked whether it was possible to synthesise a novel polymer sequence in E. coli. We have designed three operons containing combinations of genes coding for GTases, which should work together with the wzy-dependent system to synthesise a polysaccharide never before seen in nature. The three variants with similar, but not identical, enzymes aimed to demonstrate the ability to construct different monosaccharide combinations within the repeat unit and the aim was to analyse this by mass spectrometry.


In the course of operon construction we have conducted parallel comparisons between the Biobrick and Gibson Assembly methods. The purpose if this is for a comparison of the assembly methods intended for future use by iGEM teams.



The 3-Gene Inducible Plasmid


Thirdly we asked how the system already designed may be developed further.


We designed a plasmid with differentially inducible and/or repressible GTase gene expression to investigate whether it is possible to control polymer biosynthesis through gene expression rather than repeated genetic transformation.


This mini project aim was to create a three gene inducible plasmid. Each gene on the plasmid is controlled by a unique promoter, thereby giving the capability to turn each gene on and off. Why is this important? The ability to turn the genes on and off will allow the creation of a monosaccharide, a disaccharide and a trisaccharide. While this in itself will not create a library of polysaccharides available from a single E. coli colony, it is a proof of concept with the projected scope for more than 50 GTases coded for within the genome of one simple organism. The result would be a small polysaccharide factory without having to redesign the genetics every time a new bespoke polysaccharide is wanted.



Single Gene Plasmids and Enzyme Characterisation


With the database of E. coli GTases we wanted the ability to choose the optimal GTases where several options are available for catalysis of the same reaction. To improve system understanding and performance we decided to create single gene plasmids for enzyme characterisation.


Single gene expression plasmids were constructed to determine protein expression and analyse enzyme function. GTases are poorly understood and verification of the preferred donor and acceptor sugars, in addition to enzyme kinetics, will be essential for the proper functioning of the database. To determine enzyme kinetics, a glycosyltransferase assay was chosen based on the cleavage of inorganic phosphate from the pyrophosphate moiety of the sugar diphosphonucleotide carrier. The release of inorganic phosphate yields a colour change which can be detected simply using a spectrophotometer. Because release of the diphosphonucleotide carrier is quantitative to enzyme rate, the change in colour will reflect enzyme catalysis rate directly. In addition, SDS-PAGE will be used to determine the molecular weight of each GTase and compared to predicted values, as well as solubility of each GTase to check functionality in vivo.